Perry Andrew — SEC Form 4 filings

SEC reporting owner CIK 1877793. 5 Form 4 filings on record with FilingPulse; latest filed 2024-09-18.

Transaction summary — filings shown

Covers all 5 filings on record, filed 2024-01-08 to 2024-09-18. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
G1 Therapeutics, Inc. (GTHX)Chief Commercial Officer54 legs · 11,901 sh · $49,9128

Form 4 filings — Perry Andrew

FiledFormIssuerReported transactionsSource
2024-09-184G1 Therapeutics, Inc. (GTHX)Grant/award (A): 16,100 · Disposition to issuer (D): 114,482 · Code (U): 14,232 · Disposition to issuer (D): 67,050 (derivative) · Disposition to issuer (D): 32,100 (derivative)EDGAR
2024-07-084G1 Therapeutics, Inc. (GTHX)Sale (S): 1,337 @ $2.51EDGAR
2024-07-034G1 Therapeutics, Inc. (GTHX)Grant/award (A): 35,000 @ $0EDGAR
2024-05-154G1 Therapeutics, Inc. (GTHX)Sale (S): 8,151 @ $4.79EDGAR
2024-01-084G1 Therapeutics, Inc. (GTHX)Grant/award (A): 33,570 @ $0 · Sale (S): 379 @ $3.12 · Sale (S): 2,034 @ $3.12 · Grant/award (A): 67,050 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-04 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1877793 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →